Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s not grieving over a bad investment! This Scum Bag need to realize he will pay the ultimate price.
It doesn't matter if one is right or wrong. Grieving over a bad decision doesn't solve anything either. Especially when there are lots of other opportunities out there.
From reading your post, I question your investment and business experience. Silence of this long points strongly to fraud. It’s obvious Arthur has been lying to the investment community for a long time.
Mountain, I don't think we will see any PR news until they have something 'real' to say. I'm sure they are paranoid that the SEC is watching what they say to their investors. So I expect long periods of radio silence. We may not hear anything until much later in the year IMO.
Meanwhile, I'm proactively swing trading elsewhere. No sense in grieving over this stock when everything is out of our control. I say..... make money elsewhere, while you wait for this to turn around (if it turns around).
Another week has gone and no communication out of the dumb ass!
It’s time Arthur is held accountable for his actions.
Why have these thieves refused to license polarized ibuprofen?
Fact-these were supposed to be proof of concept only
My question to you was have your heard from these idiots? You are the one who felt the need to try and justify their existence, instead of answering the question!
And this is EXACTLY why I hesitated to even reply to your question - if my answer isn’t truly wanted - why ask me?
Fact, they are In business
Fact, they have products and are manufacturing and shipping them
Here’s a link to purchase products and to reach the company - I suggest those with concerns of the companies legitimacy try the product, see that orders do get shipped, verify the quality of the product by trying said product your invested in. Had I not tried the product myself I’d have no knowledge first hand that it works - my personal experience is that YES the product works as described for me and those who I gave introduced to their products - both the immunipen And muscle rub both work as described for not only myself but for those I’ve suggested they try it.
For those who would like evidence and to be able to verify for themselves
Here is a link for their products;
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
GLTA
The only sign being sent by Arthur & Grant are we screwed you & other investors and you still will buy our products.
I received 2 days ago my monthly auto renew of the immunipen. Clearly they are still in business as they have resumed shipping as they indicated they would in the Dec PR.
On a side note I’ve gifted the immunipen to a few friends who were suffering from various things and all friends I’ve shared with are seeing positive effects from using the imunapen daily as directed …. They will now also become customers too. One of the friends has family with cancer concerns and have been in direct contact with them in regards of escozine trials etc
GLTA
Things have been slow going withQNTA HOWEVER they are shipping imunapens as indicated in the Dec pr which is a good sign.
Just curious if you have had any communication out of Arthur or Graft? Either this is a total scam or they lack any business sense!
They can only hide so long! I am sure he will come up with another scam real soon to commit fraud against new investors.
Arthur needs to get off his lazy ass and start communicating!
Arthur has no reason for his silence! He is a lowlife thief! Plain and simple. Eventually he will pay the price. He will be found. Scum like him can only hide so long.
Every time somebody places an order for one of the items, they are just stealing additional funds from investors.
The only thing I am attacking you on is promoting these criminals! When you leave a positive comment, that is telling these Scumbags it ok to steal investor money.
By selling a product? A product that is tangible and is proven effective…. I call this commerce
In fact… I’m about to order more VERY EFFECTIVE products as gifts right now ..
in case any one else wants to try the products (science) they are invested in here is a link below … I literally JUST got a call from a skating coach who said this product was a game changer for her!!! Ice sports come with lots of pain as ice hurts when you fall the coach loves the product so much I’m going to get her another for teacher appreciation week
There is a sale in case anyone wants to order and try … it’s truly a great product
BUY ONE GET ONE FREE
PURCHASE AELIA MUSCLE RUB AND RECEIVE A FREE MUSCLE SPRAY USING THE CODE “Aelia_20”
Offer Valíd Until 03/03/23
https://aeliastore.com/?mc_cid=1babf548d9&mc_eid=a6ce8b5ca6
Arthur and his team are just stealing money from investors. Every time you purchase anything from these Scumbags, you are just giving them more money. Any funds they receive are just an additional way to fraud investors. Time to wake up!
Please send all messages to public forum! Investors are tired of this scam and Arthur’s incompetence.
Re: MountainInvestorTN This Message
I’m heavily invested. As many are …
The fact they have resumed shipping at least let’s me know that my investment isn’t zero … they could have stopped all together and gave up .. instead they are soldiering forward
It’s unfortunate this wasn’t the quick double up we all thought it would be. However the science I invested in is still the same science and it’s impressive imo.
I have a few choices,
Walk away from investment
Or, hold onto investment - and in holding I choose to purchase the products, use the products and subsequently buy the products as gifts for friends and loved ones who I believe will not only use and benefit from but might also subsequently become paying customers as well ..
When folks feel the positive effects and then share with their friends etc hopefully it’ll help drive brand recognition
That’s what I’m doing to try and help the company and in turn help my OWN investment and subsequently help everyone on iHub.
Orrrrr I could just yell and scream on iHub but I suspect yelling and threatening the company on iHub will yield zero return on my investment…
I’ve given 6 immunipens to 6 different families … I’ve given the muscle rub to 3 different families … so far everyone likes the products
Also, by engaging with Medolife Rx in a positive mindset - expressing I believe I’m their products - this puts me as investor in the light of a real person who wants to see them yield successful results .. I did NOT “loan” qnta money, I’m “invested” in the company … we all are … my hope, and belief, is that they will be successful… it’s just a very “Murphy’s law” so to speak riddled path
Now, to address all the anger on iHub, I understand… believe me, I understand the frustration of seeing 99.8+% down (ouch )
… I just choose optimism and doing what I can to glean information and thus monitor foreword momentum.. ie sharing the fact that indeed they Did resume immunipen sales just as they indicated they hoped to in Q1 … this was a great step forward AND showing they have not given up but instead ARE still working toward goals as stated in the Dec CC
Considering the amount of time which has gone by since any communication out of Arthur, it’s clear they have been running a scam.
Corporate officers hiding from the law is business.as.usual.in.your.code.of.ethics? And the laws these two POS, Arthur and Grant Moochaelian, have broken have stolen people's money. Please explain how this is not an issue.
This is a total scam! Arthur is totally a scumbag. Wake up!
How's that working out for your confidence in this investment?
As said in their last pr they would resume shipping imunapens with new reformulation of ingredients. I’ve personally given several as gifts to friends who so far ALL have loved the effects.
… albeit slowly … they are doing the things they indicated in the last pr
I like the escozine imunapen and am SUPER happy to have been able to have the shipping resume. If you haven’t tried it - I do recommend… as I’ve stated before, as an investor I was keen to try the thing I’m invested in - I love it and believe in the product based on how i feel using it.
Im hoping with the new formulation / viscosity that as stated in the last Dec pr that sales will pick up
GLTA
The government needs to pursue criminal charges against Arthur & Grant. It’s time they are sent to prison.
Is it concerning the CEO can't be located? Ordinarily, CEO's do not feel the need to hide if they are law abiding citizens. The stock price falling well over 99% is a direct result of his illegal actions and attack on shareholders. Should he and his son still be drawing salaries at shareholders' expense?
https://image.cnbcfm.com/api/v1/image/100654179-bernie-madoff.jpg?v=1424367433[/img]
They are wasting everyone’s time burning up what left of of investor money. Arthur and Grant are scumbags. Plain and simple! They will be lucky if spending time in prison is the only thing which happens to them. They are total trash.
I ordered products … the products I ordered then came in the mail … to answer your question to “what are they doing?” Shipping newly reformulated product
They have lied about everything else, what in good Lord makes you think they are doing anything beside bullshitting while they commit more criminal acts? Where are they?
And here:
Jedi..thanks for keeping us posted that QNTA is still actively promoting, selling and shipping product to customers! That at least demonstrates that the lights are still on.
I do care .. what exactly can I personally do about it?? I’m simply sharing they are fulfilling orders of immunipen again as the product reformulation is complete
Unfortunately…. Like everyone im sitting very much in the red . I could scream and yell - but why? It seems every one else is doing plenty of that.
I’m simply sharing things as I learn them as a courtesy to those who might want to hear / read what I’ve shared.
I could simply keep it to myself that the immunipen is shipping as they said it would be in the PR … but, I know many here are as heavily invested as I am and I actually thought some might appreciate knowing the company is in fact working and operating and SHIPPING goods that are ordered.
Ultimately, if one is invested and wants to see a return on their investment at this point we need the company to be
firstly; in Business
second; have inventory
Third; sales
Now That it’s confirmed these 3 things are indeed happening… now we can hope that the rest of the mentioned on the pr occur as well
I’m hopeful that they persevere as the alternative means I will have lost an incredibly huge amount of money
The reason I ask everyone here if they’ve tried the products is then if you’ve tried them is being a customer And an investor gives you another window into the company your invested in.
GLTA
Do you have any clue what dilution does to actual shareholders? Do you care?
You are incorrect in your assumption.
Just like many I’m an investor
I’m heavily invested and I’m sitting with 3 choices ..
1) cry and whine
2) sell at an extreme loss
3) actually use the products I’m invested in and hope the company indeed turns itself around so That I can recoup my losses
I’m NOT trying to suggest to any one else how they should handle their positions
I am conveying facts as I learn them and am sharing that the products are being shipping again - which as I stated as a customer this pleases me as the immunipen is a product I use daily - and as an investor knowing they are indeed shipping product means a source of revenue is possible for them and bodes well for us an investors
It’s obvious you are somehow involved with QNTA, beside just an investor. Please stop promoting this scam. Arthur & Grant need to be sent to prison to pay for their criminal act of defrauding investors.
Should read **VISCOSITY not velocity
“The new formula they talk about in the Dec 2022 PR indeed has a great velocity and taste as well.”
Ugh … lol should have caught my mistake
** “Viscosity” NOT velocity
Note From MedolifeRx immunapen team below, midway through my post
… on a side note I myself found The Dec PR to be very candid and informative. Also noteworthy I recently received my back ordered immunipens that are now the reformulated version - new formula that is just as qnta (MedolifeRx Dr Mikaelian) had explained in their last PR. I can 100% attest the formula is different as I used daily for about a years worth of time before the pause in shipping - the viscosity had gone through a couple iterations and truly The new formula they talk about in the Dec 2022 PR indeed has a great velocity and taste as well. ** As stated in their Dec 2022 PR they hoped to get immunapens shipping Q1 of 2023 ** and great news for me as a customer AND as an investor That is exactly what they did - got the newly reformulated shipped!! Which means they ARE getting things done as they outlined in their PR.
Here’s a quoted reply from my letter to MedolifeRx stating I was happy with the new formula and was glad to receive my shipment!
I received a reply just this week (note I order the simple escozine imunapen in the green tube - which as I stated has already resumed shipping as I received my back ordered immunipens a few days ago)
From Medolife; [{ “Our team is delighted to hear you are enjoying the new versions of the Immunapens and I am confident that we should see a steady supply of them available. We're finishing up the red Energy & Focus ones today. I believe this week we'll send out some newsletters and post on our social media regarding a promotion on the Immunapens, so we're expecting to really hit it off this month with those sales.”}]
https://medoliferx.com/
Direct quote from the PR I referred to above [{“Medolife Rx has purchased ingredients from new vendors and is in the process of reformulating the pens at this time with the goal of increasing the potency of the product line. Medolife Rx expects to begin producing and selling new batches of the Immunapen product line starting in Q1 2023”}]
Pr link ;
https://www.globenewswire.com/en/news-release/2022/12/05/2567700/0/en/Quanta-and-Medolife-Rx-Provide-Updates-on-Activities-and-Plans.html
GLTA
This stock has definitely created a level of patience and perseverance I’m not sure any one was predicting would be needed .. HOWEVER in spite of all the challenges Thankfully they haven’t given up … the arrival of the immunipen shipment is a testament they are working towards the goals set forth in the Dec 2022 PR
Followers
|
115
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
13742
|
Created
|
03/12/18
|
Type
|
Free
|
Moderators |
Quanta for 2021 will be undergoing a name change to be announced shortly as well as Quanta is in the process of expanding its product line from 4 SKUs to 38 by summer. We will also be introducing all new branding with new color schemes, new packaging, and exciting celebrity endorsements for the pain relief products and a newly introduced beauty product line. Quanta will also be working on a men’s cosmetic line in conjunction with one of the celebrity endorsements planned for late 2021. The company has hired an advertising agency to help with the rollout of the new branding expected second quarter 2021. This will work in conjunction with a major push the company is on the path of with some major big box retail chains.
Quanta Basics
Quanta is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables. Ultimately, Quanta’s mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.
The established resonance theory behind Quanta’s polarization process has many potential applications. From potentiating bio-ingredients to produce more-effective carbon-trapping plants to transformative anti-aging solutions Quanta’s technology has the opportunity to upend how commercial products are made and the benefits from them. Already we see multi-trillion-dollar global industries benefiting from Quanta’s technology.
Our proof of concept, Quanta’s market-leading CBD pain-relief rub (“Muscle Rub”), is only the first in a series of paradigm shift products to emerge from our labs. At the heart of its well-documented effectiveness is our proprietary “polarization” process, which uses electromagnetic force to markedly enhance bioactivity at the molecular level—a polarized active ingredient is more soluble and creates stronger bonds with the body’s receptors. This allows us to enhance ingredients so they work faster and more powerfully without the use of chemical by-products or cellular penetration. Quanta believes this natural solution has nearly limitless applications in the world of plant-based consumer products.
Quanta is involved in ambitious projects that we believe will reshape the next wave of climate science, sustainability, nutrition, and more. Having harnessed the technology of the future, Quanta is dedicated to bringing tomorrow’s health and wellness solutions to the billions in need today.
Discovery Synopsys
Using our product development process and business-to-business and direct-to-consumer sales approaches as a benchmark for future business, we developed the Quanta business model. Our technology’s unique ability to strengthen ingredients renders them more potent without added chemicals or penetrating cells means Quanta is in a first-of-its-kind position in the market. As the world’s first company focused on Quantum Biology we sit in a strong, but unique position in the market.
Our ability to increase ingredient efficacy by up to 500% means we are in a rare position to truly disrupt many areas of material science.
Quanta’s technology renders products superior to any on the market today. A 30% re-purchase rate (on one SKU alone) illustrates consumer appetite for the product.
Upcoming products and ventures will be designed to achieve or surpass this level of consumer benefit and uptake.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1691430/000149315221008846/form10-k.htm
Management Team
Arthur Mikaelian, Ph.D.
Chairman & CEO
One of Dr. Arthur Mikaelian’s greatest scientific contributions and groundbreaking inventions is Quantum Physics and Quantum Biology-based polarization technology, which targets molecular structure of the main ingredients in synthetic medications or natural compounds, leading to the increased potency of liquid and solid compounds, which substantially increases their therapeutic effectiveness. Dr. Mikaelian’s polarization technology has been awarded U.S. Patent 8,097,284B2 as it pertains to the Polarized Scorpion Venom solution. For the past 20 years, Dr. Mikaelian has been independently actively studying stress hormones (cortisol, epinephrine), and the master gene’s (ATF3) indirect influence on cancer cell activity and tumor progression. His initial findings quickly led him to the innovative creation of a new generation of pharmaceutical and nutraceuticals drugs, as well as expanding his interests in cancer and oncology.
Dr. Mikaelian’s education began in 1984 at the 2nd Medical Institute of Moscow and continued at the Vernadsky University of Biosphere Knowledge in Moscow, where he earned his doctorate in Biological/NeuroPsychology; he then went on to complete his postdoctoral work at Vernadsky. Dr. Mikaelian has broad experience with Quantum Physic and Quantum Biology. He also earned an MBA from the University of Bologna in Italy.
Khalid Matalka, Ph.D., SI(ASCP)
Chief Scientific Officer
Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992. After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI-ASCP) and a member at the American Society for Cancer Research since 1994.
Dr. Matalka enrolled in academia as an assistant professor in 1995, then promoted to associate and then a professor in 2004. Prof. Matalka held a dean position at two different academic institutions. Besides, Prof. Matalka was a consultant for twenty years to a JPM pharmaceutical company and a hospital diagnostic laboratory. During those 22 years, Prof. Matalka was heavily involved in research mainly on immunomodulation, cancer research, and development of immunological assays. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, MA as a Chief Biologist. While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma. In March 2020, Prof. Matalka joined Medolife Corporation as Chief Scientific Officer (CSO) and, in February 2021, became the CSO of the newly established Medolife Rx.
Prof. Matalka has 65 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals. Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
Grant Mikaelian
Executive Vice President
In 2013, Mr. Grant Mikaelian began working for an advanced biopharmaceutical company called Medolife. During his employment, he amassed a wide range of skills through managing various departments of the company. As a Marketing Sales Department Manager, he led many successful projects to improve customer experience through website development and design, enhanced customer support, streamlined ordering systems, configuration of B2C/B2B logistics, company rebranding, and preparation of marketing literature and presentations. He was later promoted to Operations Manager, overseeing and optimizing company departments on a larger scale. He was involved in production planning, project management of short and long-term goals, hiring prospective employees and contractors, corporate IT improvements, equipment procurement, international product registrations, due diligence preparation, and financial audits. He came to inspire confidence and began working closely with Dr. Arthur Mikaelian, CEO of Medolife. Soon after, Mr. Mikaelian was further promoted to Chief Business Development Officer. As the CBDO, he worked with existing and potential shareholders, was involved in domestic and international investment opportunities, managed multiple departments, increased company and product awareness, expanded product distribution channels, drafted Press Releases and articles, edited and proofread company literature, and more. Mr. Mikaelian is an organized leader with broad experiences in management and promotion of corporate growth.
Clemente Pascarella
Audit Committee
Christopher Rullan
Attorney for Mexico Division
Eduard Sahakyan
Head of R&D
Dr. Sahakyan started his career at Glendale Community College (GGC) as a lab technician for the biology department. He then pursued a biotechnology major at Pasadena City College (PCC). During his studies he interned at the Pasadena Bio Collaborative (PBC) Incubator as part of the LA Bioscience Hub research outreach program. Dr. Sahakyan worked with multiple companies including UCLA, Amgen and others during his summer internship. Upon completion, he was offered a permanent position at BCN (UCLA research collaborative) where he completed multiple projects, some of them are pending publication. In 2019, Dr. Sahakyan was offered a position in Medolife as a research associate. Within a year he was promoted to head scientist. Throughout this time, Dr. Sahakyan has worked on a number of company projects, which he presented at different local and national conferences. One of his bigger projects is the differentiation of embryonic stem cells into red blood cells. He continuously brings new ideas and initiatives to the company.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |